指南与共识头颈部肿瘤放疗

低危鼻咽癌省略IB区 elective 照射的可行性分析

The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
指南 / 共识 · Radiat Oncol · 2017-08-18

该回顾性研究纳入2009至2010年接受根治性放疗的532例鼻咽癌患者,依据2013版RTOG颈部淋巴结分区指南评估IB区转移。多因素分析显示双侧淋巴结受累、IIA区淋巴结最大轴径>20 mm或IIA区淋巴结包膜外侵犯是IB区转移的独立预测因素。无上述因素的低危组中,省略IB区 elective 照射未显著影响区域控制率和总生存,且未改善患者报告的口干症。

要点

  • 双侧淋巴结受累、IIA区淋巴结最大轴径>20 mm或包膜外侵犯是IB区转移独立预测因素。
  • 低危组省略IB区 elective 照射后IB区复发比例为0.46%,区域控制与OS无显著差异。
  • 高危组 elective IB区照射对区域控制仅边缘显著,对OS不显著,且无IB区复发。

核心结论

  • 对于无IB区转移高危因素的鼻咽癌患者,省略IB区 elective 照射未损害区域控制率和总生存。

研究设计与样本

  • 回顾性研究纳入2009至2010年在本机构接受根治性放疗的532例鼻咽癌患者。
  • IB区是否 elective 照射由医生决定,依据2013版RTOG颈部淋巴结分区指南评估淋巴结受累。

主要发现

  • 单因素分析显示N分期、双侧淋巴结转移、II区受累、IIA区受累、IIA区多区受累、IIA区淋巴结最大轴径>20 mm、颈部淋巴结最大轴径>30 mm、IIA区淋巴结坏死、IIA区包膜外侵犯与IB区转移相关。
  • 多因素分析显示双侧淋巴结受累、IIA区淋巴结最大轴径>20 mm或IIA区淋巴结包膜外侵犯是IB区转移的独立预测因素。
  • 低危组中,接受与未接受 elective IB区照射者的区域控制率和总生存无显著差异。
  • 未接受 elective IB区照射者的IB区复发比例为0.46%。
  • 高危组中, elective IB区照射对区域控制仅边缘显著,对OS在多因素分析中不显著,且无IB区区域复发。

关键数值与推荐

  • 低危组定义为无双侧淋巴结受累、无IIA区淋巴结最大轴径>20 mm且无IIA区淋巴结包膜外侵犯。
  • 未接受 elective IB区照射者的IB区复发比例为0.46%。

临床怎么用

  • 对于无双侧淋巴结受累、IIA区淋巴结最大轴径≤20 mm且无IIA区包膜外侵犯的低危鼻咽癌患者,可考虑省略IB区 elective 照射。
  • 省略IB区 elective 照射可降低颌下腺平均剂量,但未改善患者报告的口干症。

局限性

  • 本研究为单中心回顾性研究,IB区 elective 照射由医生决定,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Level IB metastasis is rare in nasopharyngeal carcinoma (NPC). The purpose of this study is to investigate the high-risk factors for level IB metastasis and evaluate the feasibility of omission of elective irradiation to level IB in the low-risk subgroups in NPC. METHODS: This retrospective study identified 532 patients with NPC treated by definitive radiation in our institution from 2009 to 2010. Level IB nodes were electively irradiated based on the physician's decision. Diagnostic head and neck MRIs were reviewed. The involvements of nodal levels were evaluated according to 2013 updated guidelines of RTOG. The correlations of level IB metastasis and other factors were studied using Chi-square test and logistic regression model. Log-rank tests were used to compare survival rates. Cox proportional-hazards models were used to evaluate the effect of various factors. Patient-reported xerostomia was recoded in every follow-up and the extents of delayed xerostomia at 1 year post-radiation were compared between those with/without elective level IB irradiation. RESULTS: N stage, bilateral nodal metastasis, level II involvement, level IIA involvement, level IIA with multiple levels involvement, maximal axial diameter (MAD) of level IIA nodes > 20 mm, MAD of neck lymph nodes > 30 mm, necrosis of level IIA nodes, extracapsular spread of level IIA correlated with level IB metastasis by univariate analysis. In multivariate analysis (MVA), bilateral nodal involvement, MAD of level IIA nodes > 20 mm or extracapsular spread of level IIA nodes, were independent predictive factors for level IB metastasis. Patients without either these factors were denoted low-risk group and the rest high-risk group. Of the low-risk group, there was no significant difference of regional control and overall survival (OS) between those with or without elective irradiation. The percentage of level IB recurrence of those without elective irradiation was 0.46%. Elective level IB irradiation was not significant upon MVA both for regional control and OS. Of the high-risk group, elective level IB irradiation was marginal significant for regional control, but not for OS upon MVA. No regional recurrence located at level IB. Overall, omission of elective irradiation to level IB reduced the mean doses of submandibular glands, but did not improve patient-reported xerostomia. CONCLUSION: For patients without high-risk factors of level IB metastasis, omission of elective level IB irradiation did not impair regional control and OS in NPC.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Ou X, Miao Y, Wang X, et al. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels. Radiat Oncol. 2017. PMID: 28821277. doi:10.1186/s13014-017-0869-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。